| Year |
Citation |
Score |
| 2024 |
Vella L, Sternjakob A, Lohse S, Fingerle A, Sperling T, Wickenhauser C, Stöckle M, Vogt T, Roemer K, Ołdak M, Smola S. The cutaneous beta human papillomavirus type 8 E6 protein induces CCL2 through the CEBPα/miR-203/p63 pathway to support an inflammatory microenvironment in epidermodysplasia verruciformis skin lesions. Frontiers in Cellular and Infection Microbiology. 14: 1336492. PMID 38510961 DOI: 10.3389/fcimb.2024.1336492 |
0.716 |
|
| 2022 |
Mohr T, Zwick A, Hans MC, Bley IA, Braun FL, Khalmurzaev O, Matveev VB, Loertzer P, Pryalukhin A, Hartmann A, Geppert CI, Loertzer H, Wunderlich H, Naumann CM, Kalthoff H, ... ... Smola S, et al. The prominent role of the S100A8/S100A9-CD147 axis in the progression of penile cancer. Frontiers in Oncology. 12: 891511. PMID 36303837 DOI: 10.3389/fonc.2022.891511 |
0.421 |
|
| 2022 |
Sternjakob-Marthaler A, Berkó-Göttel B, Rissland J, Schöpe J, Taurian E, Müller H, Weber G, Lohse S, Lamberty T, Holleczek B, Stoffel H, Hauptmann G, Giesen M, Firk C, Schanzenbach A, ... ... Smola S, et al. Human papillomavirus vaccination of girls in the German model region Saarland: Insurance data-based analysis and identification of starting points for improving vaccination rates. Plos One. 17: e0273332. PMID 36054196 DOI: 10.1371/journal.pone.0273332 |
0.341 |
|
| 2022 |
Bley IA, Zwick A, Hans MC, Thieser K, Wagner V, Ludwig N, Khalmurzaev O, Matveev VB, Loertzer P, Pryalukhin A, Hartmann A, Geppert CI, Loertzer H, Wunderlich H, Naumann CM, ... ... Smola S, et al. DKK1 inhibits canonical Wnt signaling in human papillomavirus-positive penile cancer cells. Translational Oncology. 15: 101267. PMID 34773828 DOI: 10.1016/j.tranon.2021.101267 |
0.468 |
|
| 2021 |
Kühn JP, Schmid W, Körner S, Bochen F, Wemmert S, Rimbach H, Smola S, Radosa JC, Wagner M, Morris LGT, Bozzato V, Bozzato A, Schick B, Linxweiler M. HPV Status as Prognostic Biomarker in Head and Neck Cancer-Which Method Fits the Best for Outcome Prediction? Cancers. 13. PMID 34572957 DOI: 10.3390/cancers13184730 |
0.421 |
|
| 2021 |
Gross GE, Werner RN, Avila Valle GL, Bickel M, Brockmeyer NH, Doubek K, Gallwas J, Gieseking F, Haase H, Hillemanns P, Ikenberg H, Jongen J, Kaufmann AM, Klußmann JP, von Knebel Doeberitz M, ... ... Smola S, et al. German evidence and consensus-based (S3) guideline: Vaccination recommendations for the prevention of HPV-associated lesions. Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : Jddg. PMID 33634583 DOI: 10.1111/ddg.14438 |
0.427 |
|
| 2020 |
Bernhard MC, Zwick A, Mohr T, Gasparoni G, Khalmurzaev O, Matveev VB, Loertzer P, Pryalukhin A, Hartmann A, Geppert CI, Loertzer H, Wunderlich H, Naumann CM, Kalthoff H, Junker K, ... Smola S, et al. The HPV and p63 status in penile cancer are linked with the infiltration and therapeutic availability of neutrophils. Molecular Cancer Therapeutics. PMID 33273057 DOI: 10.1158/1535-7163.MCT-20-0173 |
0.458 |
|
| 2020 |
Smola S. Human Papillomaviruses and Skin Cancer. Advances in Experimental Medicine and Biology. 1268: 195-209. PMID 32918220 DOI: 10.1007/978-3-030-46227-7_10 |
0.553 |
|
| 2019 |
Smola S. Immune deviation and cervical carcinogenesis. Papillomavirus Research (Amsterdam, Netherlands). 7: 164-167. PMID 30980967 DOI: 10.1016/J.Pvr.2019.03.006 |
0.401 |
|
| 2019 |
Hölters S, Khalmurzaev O, Pryalukhin A, Loertzer P, Janssen M, Heinzelbecker J, Ueberdiek S, Pfuhl T, Smola S, Agaimy A, Geppert C, Loertzer H, Krah X, Wunderlich H, Wagenpfeil S, et al. Challenging the prognostic impact of the new WHO and TNM classifications with special emphasis on HPV status in penile carcinoma. Virchows Archiv : An International Journal of Pathology. 475: 211-221. PMID 30972551 DOI: 10.1007/S00428-019-02566-0 |
0.461 |
|
| 2019 |
Venuti A, Lohse S, Tommasino M, Smola S. Cross-talk of cutaneous beta human papillomaviruses and the immune system: determinants of disease penetrance. Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences. 374: 20180287. PMID 30955489 DOI: 10.1098/Rstb.2018.0287 |
0.58 |
|
| 2019 |
Walch-Rückheim B, Ströder R, Theobald L, Pahne-Zeppenfeld J, Hegde S, Kim YJ, Bohle RM, Juhasz-Böss I, Solomayer EF, Smola S. Cervical cancer-instructed stromal fibroblasts enhance IL-23 expression in dendritic cells to support expansion of Th17 cells. Cancer Research. PMID 30696656 DOI: 10.1158/0008-5472.Can-18-1913 |
0.393 |
|
| 2019 |
Müller CSL, Kreie L, Bochen F, Pfuhl T, Smola S, Gräber S, Vogt T, Schick B, Linxweiler M. Expression of 3q oncogene in atypical fibroxanthoma-immunohistochemical analysis of 41 cases and correlation with clinical, viral and histopathologic features. Oncology Letters. 17: 1768-1776. PMID 30675236 DOI: 10.3892/Ol.2018.9767 |
0.306 |
|
| 2019 |
Zeuschner P, Ueberdiek S, Pryalukhin A, Veith C, Saar M, Smola S, Bohle RM, Junker K, Stöckle M, Heinzelbecker J. Human Papillomavirus-Associated Invasive Condylomas in a Man with Immunosuppressive Comorbidities. Urologia Internationalis. 102: 238-242. PMID 30130762 DOI: 10.1159/000491098 |
0.541 |
|
| 2018 |
Pfister HJ, Gariglio M, Smola S. Editorial: Human Papillomaviruses and Polyomaviruses in Skin Cancer. Frontiers in Microbiology. 9: 2778. PMID 30498488 DOI: 10.3389/Fmicb.2018.02778 |
0.315 |
|
| 2018 |
Stroeder R, Walch-Rückheim B, Fischbach J, Juhasz-Böss I, Rübe C, Solomayer EF, Smola S. Oncostatin M treatment increases the responsiveness toward cisplatin-based chemoradiotherapy in cervical cancer cells in a STAT3-dependent manner. Oncology Letters. 16: 3351-3358. PMID 30127934 DOI: 10.3892/Ol.2018.8987 |
0.438 |
|
| 2018 |
Podgórska M, Ołdak M, Marthaler A, Fingerle A, Walch-Rückheim B, Lohse S, Müller CSL, Vogt T, Ustav M, Wnorowski A, Malejczyk M, Majewski S, Smola S. Chronic Inflammatory Microenvironment in Epidermodysplasia Verruciformis Skin Lesions: Role of the Synergism Between HPV8 E2 and C/EBPβ to Induce Pro-Inflammatory S100A8/A9 Proteins. Frontiers in Microbiology. 9: 392. PMID 29563902 DOI: 10.3389/Fmicb.2018.00392 |
0.74 |
|
| 2018 |
Wemmert S, Linxweiler M, Lerner C, Bochen F, Kulas P, Linxweiler J, Smola S, Urbschat S, Wagenpfeil S, Schick B. Combinational chromosomal aneuploidies and HPV status for prediction of head and neck squamous cell carcinoma prognosis in biopsies and cytological preparations. Journal of Cancer Research and Clinical Oncology. 144: 1129-1141. PMID 29560516 DOI: 10.1007/S00432-018-2629-1 |
0.468 |
|
| 2018 |
Hölters S, Khalmurzaev O, Heinzelmann J, Pryalukhin A, Loertzer P, Matveev V, Janssen M, Torsten P, Smola S, Bohle R, Fuhrich N, Geppert C, Loertzer H, Krah X, Wunderlich H, et al. Prognostic potential of histopathology combined with HPV status and microRNAs in penile squamous cell carcinomas European Urology Supplements. 17: e2526. DOI: 10.1016/s1569-9056(18)33006-9 |
0.396 |
|
| 2018 |
Hölters S, Heinzelmann J, Khalmurzaev O, Matveev V, Loertzer P, Ueberdiek S, Janssen M, Pfuhl T, Smola S, Bohle R, Pryalukhin A, Fuhrich N, Geppert C, Hartmann A, Loertzer H, et al. Relevance of HPV-status and histopathology for prognosis and miRNA expression in patients with penile carcinoma European Urology Supplements. 17: e45. DOI: 10.1016/S1569-9056(18)30883-2 |
0.322 |
|
| 2017 |
Smola S. Immunopathogenesis of HPV-Associated Cancers and Prospects for Immunotherapy. Viruses. 9. PMID 28895886 DOI: 10.3390/V9090254 |
0.584 |
|
| 2017 |
Krecké N, Smola S, Vogt T, Müller CSL. HPV-47-Induced and Tattoo-associated Verrucae Planae: Report of a Case and Review of the Literature. Dermatology and Therapy. PMID 28836173 DOI: 10.1007/S13555-017-0197-Y |
0.527 |
|
| 2017 |
Smola S, Trimble C, Stern PL. Human papillomavirus-driven immune deviation: challenge and novel opportunity for immunotherapy. Therapeutic Advances in Vaccines. 5: 69-82. PMID 28794879 DOI: 10.1177/2051013617717914 |
0.414 |
|
| 2017 |
Marthaler AM, Podgorska M, Feld P, Fingerle A, Knerr-Rupp K, Grässer F, Smola H, Roemer K, Ebert E, Kim YJ, Bohle RM, Müller CSL, Reichrath J, Vogt T, Malejczyk M, ... ... Smola S, et al. Identification of C/EBPα as a novel target of the HPV8 E6 protein regulating miR-203 in human keratinocytes. Plos Pathogens. 13: e1006406. PMID 28640877 DOI: 10.1371/Journal.Ppat.1006406 |
0.535 |
|
| 2017 |
Hölters S, Khalmurzaev O, Ueberdiek S, Loertzer P, Pfuhl T, Pryalukhin A, Hartmann A, Janssen M, Loertzer H, Wunderlich H, Hauschild E, Bohle R, Smola S, Stöckle M, Matveev V, et al. Histopathologic and prognostic correlations regarding human papillomavirus (HPV) infection in penile squamous cell carcinomas (SCC) considering the novel 2016 WHO classification European Urology Supplements. 16: e1242. DOI: 10.1016/S1569-9056(17)30771-6 |
0.423 |
|
| 2016 |
Bochen F, Adisurya H, Wemmert S, Lerner C, Greiner M, Zimmermann R, Hasenfus A, Wagner M, Smola S, Pfuhl T, Bozzato A, Al Kadah B, Schick B, Linxweiler M. Effect of 3q oncogenes SEC62 and SOX2 on lymphatic metastasis and clinical outcome of head and neck squamous cell carcinomas. Oncotarget. PMID 28002801 DOI: 10.18632/Oncotarget.13986 |
0.307 |
|
| 2016 |
Walch-Rückheim B, Pahne-Zeppenfeld J, Fischbach J, Wickenhauser C, Horn LC, Tharun L, Büttner R, Mallmann P, Stern P, Kim YJ, Bohle RM, Rübe C, Ströder R, Juhasz-Böss I, Solomayer EF, ... Smola S, et al. STAT3/IRF1 pathway activation sensitizes cervical cancer cells to chemotherapeutic drugs. Cancer Research. PMID 27216197 DOI: 10.1158/0008-5472.Can-14-1306 |
0.449 |
|
| 2016 |
Smola S. RIPK3-a predictive marker for personalized immunotherapy? Oncoimmunology. 5: e1075695. PMID 27141374 DOI: 10.1080/2162402X.2015.1075695 |
0.303 |
|
| 2016 |
Strittmatter GE, Sand J, Sauter M, Seyffert M, Steigerwald R, Fraefel C, Smola S, French LE, Beer HD. IFN-γ Primes Keratinocytes for HSV-1-Induced Inflammasome Activation. The Journal of Investigative Dermatology. 136: 610-620. PMID 26739094 DOI: 10.1016/J.Jid.2015.12.022 |
0.332 |
|
| 2015 |
Walch-Rückheim B, Mavrova R, Henning M, Vicinus B, Kim YJ, Bohle RM, Juhasz-Böss I, Solomayer EF, Smola S. Stromal Fibroblasts Induce CCL20 through IL6/C/EBPβ to Support the Recruitment of Th17 Cells during Cervical Cancer Progression. Cancer Research. PMID 26631268 DOI: 10.1158/0008-5472.Can-15-0732 |
0.474 |
|
| 2015 |
Rolfs F, Huber M, Kuehne A, Kramer S, Haertel E, Muzumdar S, Wagner J, Tanner Y, Böhm F, Smola S, Zamboni N, Levesque MP, Dummer R, Beer HD, Hohl D, et al. Nrf2 Activation Promotes Keratinocyte Survival during Early Skin Carcinogenesis via Metabolic Alterations. Cancer Research. PMID 26530903 DOI: 10.1158/0008-5472.Can-15-0614 |
0.341 |
|
| 2015 |
Schmidt SV, Seibert S, Walch-Rückheim B, Vicinus B, Kamionka EM, Pahne-Zeppenfeld J, Solomayer EF, Kim YJ, Bohle RM, Smola S. RIPK3 expression in cervical cancer cells is required for PolyIC-induced necroptosis, IL-1α release, and efficient paracrine dendritic cell activation. Oncotarget. 6: 8635-47. PMID 25888634 |
0.319 |
|
| 2015 |
Linxweiler M, Bochen F, Wemmert S, Lerner C, Hasenfus A, Bohle RM, Al-Kadah B, Takacs ZF, Smola S, Schick B. Combination of p16(INK4a) /Ki67 immunocytology and hpv polymerase chain reaction for the noninvasive analysis of HPV involvement in head and neck cancer. Cancer Cytopathology. 123: 219-29. PMID 25557267 DOI: 10.1002/Cncy.21512 |
0.539 |
|
| 2014 |
Gross G, Becker N, Brockmeyer NH, Esser S, Freitag U, Gebhardt M, Gissmann L, Hillemanns P, Grundhewer H, Ikenberg H, Jessen H, Kaufmann A, Klug S, Klußmann JP, Nast A, ... ... Smola S, et al. Vaccination against HPV-Associated Neoplasias: Recommendations from the Current S3 Guideline of the HPV Management Forum of the Paul-Ehrlich Society - AWMF Guidelines, Registry No. 082-002 (short version), valid until Dec. 31st, 2018. Geburtshilfe Und Frauenheilkunde. 74: 233-241. PMID 27064858 DOI: 10.1055/S-0033-1360170 |
0.547 |
|
| 2014 |
Gross G, Becker N, Brockmeyer NH, Esser S, Freitag U, Gebhardt M, Gissmann L, Hillemanns P, Grundhewer H, Ikenberg H, Jessen H, Kaufmann A, Klug S, Klussmann JP, Nast A, ... ... Smola S, et al. [Vaccination against HPV-associated neoplasias]. Laryngo- Rhino- Otologie. 93: 848-56. PMID 25437625 DOI: 10.1055/S-0034-1382013 |
0.467 |
|
| 2014 |
Pahne-Zeppenfeld J, Schröer N, Walch-Rückheim B, Oldak M, Gorter A, Hegde S, Smola S. Cervical cancer cell-derived interleukin-6 impairs CCR7-dependent migration of MMP-9-expressing dendritic cells. International Journal of Cancer. Journal International Du Cancer. 134: 2061-73. PMID 24136650 DOI: 10.1002/ijc.28549 |
0.639 |
|
| 2014 |
Gross G, Becker N, Brockmeyer NH, Esser S, Freitag U, Gebhardt M, Gissmann L, Hillemanns P, Grundhewer H, Ikenberg H, Jessen H, Kaufmann A, Klug S, Klumann JP, Nast A, ... ... Smola S, et al. Vaccination against HPV-Associated Neoplasias Geburtshilfe Und Frauenheilkunde. 74: 233-241. DOI: 10.1055/s-0033-1360170 |
0.372 |
|
| 2012 |
Glas M, Smola S, Pfuhl T, Pokorny J, Bohle RM, Bücker A, Kamradt J, Volk T. Fatal multiorgan failure associated with disseminated herpes simplex virus-1 infection: a case report. Case Reports in Critical Care. 2012: 359360. PMID 24826337 DOI: 10.1155/2012/359360 |
0.312 |
|
| 2012 |
Sperling T, Ołdak M, Walch-Rückheim B, Wickenhauser C, Doorbar J, Pfister H, Malejczyk M, Majewski S, Keates AC, Smola S. Human papillomavirus type 8 interferes with a novel C/EBPβ-mediated mechanism of keratinocyte CCL20 chemokine expression and Langerhans cell migration. Plos Pathogens. 8: e1002833. PMID 22911498 DOI: 10.1371/Journal.Ppat.1002833 |
0.724 |
|
| 2011 |
Gatzioufas Z, Oldak M, Schnaidt A, Smola S, Seitz B. Graft-to-host transmission of herpes simplex virus -- myth or reality? Acta Ophthalmologica. 89: e473-4; author reply. PMID 21756291 DOI: 10.1111/j.1755-3768.2011.02192.x |
0.516 |
|
| 2011 |
Oldak M, Tolzmann L, Wnorowski A, Podgórska MJ, Silling S, Lin R, Hiscott J, Müller CS, Vogt T, Smola H, Smola S. Differential regulation of human papillomavirus type 8 by interferon regulatory factors 3 and 7. Journal of Virology. 85: 178-88. PMID 20980500 DOI: 10.1128/Jvi.00998-10 |
0.749 |
|
| 2010 |
De Andrea M, Rittà M, Landini MM, Borgogna C, Mondini M, Kern F, Ehrenreiter K, Baccarini M, Marcuzzi GP, Smola S, Pfister H, Landolfo S, Gariglio M. Keratinocyte-specific stat3 heterozygosity impairs development of skin tumors in human papillomavirus 8 transgenic mice. Cancer Research. 70: 7938-48. PMID 20876801 DOI: 10.1158/0008-5472.CAN-10-1128 |
0.466 |
|
| 2010 |
Gross G, Gissmann L, Hillemanns P, Ikenberg H, Kaufmann AM, Petry KU, Pfister H, Schneede P, Schneider A, Smola S. [Prevention of HPV-associated neoplasias by vaccination - short version of the German S3 (level 3) guideline]. Deutsche Medizinische Wochenschrift (1946). 135: 1083-6. PMID 20486060 DOI: 10.1055/S-0030-1253704 |
0.454 |
|
| 2010 |
Oldak M, Maksym RB, Sperling T, Yaniv M, Smola H, Pfister HJ, Malejczyk J, Smola S. Human papillomavirus type 8 E2 protein unravels JunB/Fra-1 as an activator of the beta4-integrin gene in human keratinocytes. Journal of Virology. 84: 1376-86. PMID 19923172 DOI: 10.1128/JVI.01220-09 |
0.673 |
|
| 2009 |
Dole VS, Smola H, Dooley S, Said HM, Oldak M, Pfister HJ, Smola S. The adenoviral E1A oncoprotein activates the Smad7 promoter: requirement of a functional E-box. International Journal of Oncology. 35: 1493-8. PMID 19885573 |
0.653 |
|
| 2009 |
Marcuzzi GP, Hufbauer M, Kasper HU, Weißenborn SJ, Smola S, Pfister H. Spontaneous tumour development in human papillomavirus type 8 E6 transgenic mice and rapid induction by UV-light exposure and wounding. The Journal of General Virology. 90: 2855-2864. PMID 19692543 DOI: 10.1099/vir.0.012872-0 |
0.437 |
|
| Show low-probability matches. |